Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules in satchet | Doc History | Gilead Sciences Ltd

Home
Medicines
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules in satchet

Name:
Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules in satchet
Company:
Gilead Sciences Ltd
Active Ingredients:
Ledipasvir, Sofosbuvir
Legal Category:
Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 10/07/20

Summary of Product Characteristics last updated on medicines.ie: 10/7/2020

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Click on this link to Download PDF directly

Company Products

Medicine Name	Active Ingredients
Medicine Name AmBisome (Liposomal Amphotericin)	Active Ingredients Amphotericin B
Medicine Name Atripla 600 mg/200 mg/245 mg film- coated tablets	Active Ingredients Efavirenz, Emtricitabine, Tenofovir disoproxil fumarate
Medicine Name Biktarvy 50 mg/200 mg/25 mg film-coated tablets	Active Ingredients Emtricitabine, Tenofovir alafenamide fumarate, Bictegravir sodium
Medicine Name Cayston 75 mg powder and solvent for nebuliser solution	Active Ingredients Aztreonam lysine
Medicine Name Descovy 200 mg/10 mg film-coated tablets	Active Ingredients Emtricitabine, Tenofovir alafenamide fumarate
Medicine Name Descovy 200 mg/25 mg film-coated tablets	Active Ingredients Emtricitabine, Tenofovir alafenamide fumarate
Medicine Name Emtriva 10 mg/ml oral solution	Active Ingredients Emtricitabine
Medicine Name Emtriva 200 mg hard capsules	Active Ingredients Emtricitabine
Medicine Name Epclusa 400 mg/100 mg and 200 mg/50 mg film-coated tablets	Active Ingredients Sofosbuvir, Velpatasvir
Medicine Name Eviplera 200 mg/25 mg/245 mg film-coated tablets	Active Ingredients Emtricitabine, Rilpivirine Hydrochloride, Tenofovir disoproxil fumarate
Medicine Name Genvoya 150mg/150mg/200mg/10mg film coated tablets	Active Ingredients Cobicistat, Elvitegravir, Emtricitabine, Tenofovir alafenamide fumarate
Medicine Name Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules in satchet	Active Ingredients Ledipasvir, Sofosbuvir
Medicine Name Harvoni 90 mg/400 mg and 45 mg/200 mg film-coated tablets	Active Ingredients Ledipasvir, Sofosbuvir
Medicine Name Hepsera 10 mg tablets	Active Ingredients Adefovir dipivoxil
Medicine Name Jyseleca 100 mg and 200 mg film-coated tablets	Active Ingredients Filgotinib
Medicine Name Odefsey 200 mg/25 mg/25 mg film-coated tablets	Active Ingredients Emtricitabine, Rilpivirine Hydrochloride, Tenofovir alafenamide fumarate
Medicine Name Sovaldi 150 mg and 200 mg coated granules in sachet	Active Ingredients Sofosbuvir
Medicine Name Sovaldi 400 mg and 200 mg film-coated tablets	Active Ingredients Sofosbuvir
Medicine Name Stribild 150 mg/150 mg/200 mg/245 mg film coated tablets	Active Ingredients Cobicistat, Elvitegravir, Emtricitabine, Tenofovir disoproxil fumarate
Medicine Name Truvada film-coated tablets	Active Ingredients Emtricitabine, Tenofovir disoproxil fumarate
Medicine Name Tybost 150mg film coated tablets	Active Ingredients Cobicistat
Medicine Name Veklury 100 mg concentrate for solution for infusion	Active Ingredients Remdesivir
Medicine Name Veklury 100 mg powder for concentrate for solution for infusion	Active Ingredients Remdesivir
Medicine Name Vemlidy 25 mg film coated tablets	Active Ingredients Tenofovir alafenamide fumarate
Medicine Name Viread 245 mg film-coated tablets	Active Ingredients Tenofovir disoproxil fumarate

Items Per Page :

1 - 0 of 29 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 10 July 2020 SPC

Reasons for updating

New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 10 July 2020 PIL

Reasons for updating

New PIL for new product